Swiss genomic analytics and AI firm Sophia Genetics has closed on a $30 million Series D round, led by new investor Balderton Capital.
Genome Medical will use the platform for ongoing examination of patients' genomic data to augment data analysis, annotation, and interpretation.
The group is proposing women ages 30 to 65 be screened with cervical cytology every three years or receive testing for high-risk HPV every five years.
The company said that it plans to use the funds to develop NGS assays in the oncology and precision medicine space, and expand its US commercial team.
A pair of studies has established a potential role for specific gut bacteria in the progression of MS, suggesting therapeutic targeting of the microbiota as a potential treatment.
The institute will provide gene editing services and genetically modified cell lines to Analytical Biological Services.
The deals will expand the availability of Admera's pharmacogenomics testing services to markets including Singapore, Hong Kong, Korea, and Taiwan.
Ambry will provide genetic testing in NorthShore’s Genomic Health Initiative in hopes of moving precision medicine into clinical practice.
23andMe said it plans to use the money raised to grow its customer base, expand its therapeutics group, and invest in its genetic research platform.
The firms will use MGI's sequencing technology and Curetis' sample prep platform and antibiotic resistance database to develop IVDs, initially for China.
The Series A round included investments from Illumina Ventures, Merck KGaA's M Ventures, Sofinnova Partners, Kurma Partners, and Idinvest Partners.
The firms will comarket AATI's automated CE systems for quality control analysis of nucleic acids in Illumina's next-generation sequencing workflows.
A meta-analysis based on genotyping data for more than 400,000 people with or without the disease led to 17 new risk loci mined for candidate genes
The nonexclusive license allows Arcadia to use the patented technology to develop nutritional and agricultural productivity traits in its core crops.
A team of Australian researchers reconstructed 7,280 bacterial and 623 archaeal genomes from publicly availably metagenomic data.
The British-based firm says that its assay detects hepatitis C via a single-use, disposable cartridge within 90 minutes of testing.
The companies will market Angle's Parsortix system for harvesting circulating tumor cells with Qiagen's liquid biopsy product portfolio.
Last week, GenomeWeb's readers were most interested in llumina's new patent infringement lawsuit against Premaitha Health in the UK.
The joint GenomeWeb/Bank of America survey showed that most respondents had one preferred supplier despite the prevalence of a multitude of online catalogs.
Until March 2018, when the patent in question expires, Cenata will have its Harmony test performed by Medirex in Slovakia.
The company's Hong Kong laboratory was established in 2010 and was accredited by the College of American Pathologists in 2013.
The Ann Arbor-based biotech startup will use the funding to develop its microbubble technology that allows for removal of biomolecules from biological samples.
Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.
Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.
Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.
In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.